203664-05-5

Basic information

• Product Name: Carbamic acid, (1H-imidazol-2-ylmethyl)-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, (1H-imidazol-2-ylmethyl)-, 1,1-dimethylethyl ester (9CI);tert-butyl N-(1H-imidazol-2-ylmethyl)carbamate
• CAS NO: 203664-05-5
• Molecular Formula: C₉H₁₅N₃O₂
• Molecular Weight: 197.2343
• Product Categories: N-BOC
• Mol File: 203664-05-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbamic acid, (1H-imidazol-2-ylmethyl)-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (1H-imidazol-2-ylmethyl)-, 1,1-dimethylethyl ester (9CI)(203664-05-5)
• EPA Substance Registry System: Carbamic acid, (1H-imidazol-2-ylmethyl)-, 1,1-dimethylethyl ester (9CI)(203664-05-5)

Safety Data

• Hazardous Substances Data: 203664-05-5(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 22600-77-7 (1H-imidazol-2-yl)methanamine dihydrochloride 
• 53332-80-2 2-aminomethylimidazole 

Relevant articles and documents

CYCLIC INHIBITORS OF HEPATITIS B VIRUS

The present invention relates to compounds that are inhibitors of hepatitis B virus (HBV). Compounds of this invention are useful alone or in combination with other agents for treating, ameliorating, preventing or curing HBV infection and related conditions. The present invention also relates to pharmaceutical compositions containing said compounds.

Benzopiperidine derivatives

Benzopiperidine derivatives represented by formula (I), salts thereof or hydrates thereof, processes for producing the same and drugs comprising the same: wherein the variables are as described in the specification. These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and rejection reaction accompanying organ transplantation.